StonvexLoading…
StonvexStonvexStonvexCore line items from LEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $34.19B | $35.44B | $34.23B | $33.67B |
Operating Income | $2.81B | $5.18B | $5.20B | $6.01B |
Net Income | $2.08B | $3.93B | $3.94B | $4.61B |
EPS (Diluted) | $7.98 | $14.31 | $13.73 | $15.72 |
Total Assets | $34.43B | $41.31B | $39.23B | $37.98B |
Total Liabilities | $12.29B | $13.29B | $12.53B | $13.74B |
Cash & Equivalents | $3.76B | $4.91B | $6.57B | $4.82B |
Free Cash Flow OCF − CapEx | $28.18M | $2.23B | $5.08B | $3.21B |
Shares Outstanding | 257.75M | 272.02M | 283.32M | 289.82M |